Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Cluster of Insider Sales at IT Research Firm – Should You Sell? Guys at Baron Say No; Plus Other Insider Trading

Board Member of Catalent Buys Sizable Block of Shares

One member of Catalent Inc. (NYSE:CTLT)’s nine-member board piled up some shares this week as well. Board member Donald E. Morel bought 10,000 shares on Wednesday at prices ranging from $29.20 to $29.32 per share. Dr. Morel currently owns an aggregate of 18,799 shares after the purchase.

The provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products has seen its market capitalization rise by 22% in the past year. Catalent Inc. (NYSE:CTLT) recently announced the completion of its acquisition of Accucaps Industries Limited, a Canada-based developer and manufacturer of over-the-counter high-potency and conventional pharmaceutical softgels. As Catalent has long-term supply agreements, which represent a revenue stream over a period of years, the company’s backlog shows future service revenues from work not yet completed. The company’s backlog totaled $958.3 million at the end of December, up from $827.5 million on June 30. More importantly, Catalent anticipates recognizing roughly 67% of revenue from the December backlog by the end of June of 2017. Benjamin A. Smith’s Laurion Capital Management trimmed its position in Catalent Inc. (NYSE:CTLT) by 51% during the fourth quarter, to around 989,000 shares.

Follow Catalent Inc. (NYSE:CTLT)
Trade (NYSE:CTLT) Now!

CFO of Struggling e-Commerce Software Firm Boosts Equity Stake After Share Price Plunge

A well-informed and influential member of ChannelAdvisor Corp (NYSE:ECOM)’s executive team also purchased some shares earlier this week. Chief Financial Officer Mark Cook, former Vice President of Finance and Controller of open-source technology firm Red Hat Inc. (NYSE:RHT), snatched up 10,000 shares on Thursday at a weighted average price of $10.67 per share. Mr. Cook currently owns a total of 105,058 shares.

The insider purchase comes shortly after the shares of the e-commerce software firm plunged by nearly 25% on the day following the company’s release of lower-than-expected financial results for the fourth quarter. ChannelAdvisor Corp (NYSE:ECOM), a provider of SaaS solutions enabling retailer and branded manufacting customers to integrate and manage their merchandise sales across hundreds of online channels, has opted to focus more on larger customers in recent years, but the company has been struggling with execution. The software company has initiated an aggressive overhaul process, shuffling leadership roles and adjusting its pricing strategy. Although demand for ChannelAdvisor’s platform exists, the company has been struggling to close deals due to pricing hurdles and the executive change-ups, among other things. Should investors anticipate an inflection point in 2017? The insider transaction mentioned above seems to suggest so. The shares of ChannelAdvisor are 26% in the red thus far in 2017. Mark N. Diker’s Diker Management added a 175,466-share position in ChannelAdvisor Corp (NYSE:ECOM) to its portfolio during the December quarter.

Follow Channeladvisor Corp (NYSE:ECOM)
Trade (NYSE:ECOM) Now!

Let’s head to the last page of this insider trading article, where we’ll focus our attention on the fresh insider selling observed at two other companies.

DOWNLOAD FREE REPORT: Warren Buffett's Best Stock Picks

Let Warren Buffett, George Soros, Steve Cohen, and Daniel Loeb WORK FOR YOU.

If you want to beat the low cost index funds by 19 percentage points per year, look no further than our monthly newsletter.In this free report you can find an in-depth analysis of the performance of Warren Buffett's entire historical stock picks. We uncovered Warren Buffett's Best Stock Picks and a way to for Buffett to improve his returns by more than 4 percentage points per year.

Bonus Biotech Stock Pick: You can also find a detailed bonus biotech stock pick that we expect to return more than 50% within 12 months.
Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.